Viewing Study NCT06142461



Ignite Creation Date: 2024-05-06 @ 7:48 PM
Last Modification Date: 2024-10-26 @ 3:14 PM
Study NCT ID: NCT06142461
Status: WITHDRAWN
Last Update Posted: 2024-05-24
First Post: 2023-11-16

Brief Title: Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Sponsor: PharmaJet Inc
Organization: PharmaJet Inc

Study Overview

Official Title: Safety and Immunogenicity of Human Papillomavirus Quadrivalent Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Status: WITHDRAWN
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Change in landscape of HPV treatment
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to evaluate the safety and immunogenicity of an HPV Vaccine Gardasil delivered by intramuscular needle-free injection and intradermal needle-free injection The main question it aims to answer is

Is intramuscular and intradermal needle-free injection of Gardasil safe
Does intramuscular and intradermal needle-free vaccination with Gardasil illicit an immune response

Participants will

Receive Gardasil by intramuscular needle-free injection intradermal needle-free injection or needle and syringe injection
Provide blood samples
Complete physical exams
Complete diaries
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
1R44CA261326-01A1 NIH None httpsreporternihgovquickSearch1R44CA261326-01A1